ORBUSNEICH MEDICAL PTE. LTD.

OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, OrbusNeich sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. As of 30 June, 2025, OrbusNeich has more than 250 granted patents and published patent applications worldwide. Its in-house R&D team has more than two decades of product development experience and has developed world-leading proprietary technologies, including its Scoreflex NC product, the world’s smallest profile non-compliant scoring balloon; its proprietary “drug plus antibody” COMBO dual therapy stent; and its JADE non-compliant peripheral balloon, the first and only non-compliant over-the-wire PTA balloon approved by the FDA that is compatible with all guidewire systems in the U.S. OrbusNeich is listed on the Main Board of The Stock Exchange of Hong Kong Limited (“HKEX”), under the stock code 6929. For more information and news, visit updated on 15 August 2025)